Analyst Ratings for Sabra Health Care REIT
Portfolio Pulse from Benzinga Insights
Sabra Health Care REIT (NASDAQ:SBRA) has received mixed analyst ratings in the last quarter, with 2 bullish, 1 somewhat bullish, and 4 indifferent. The average 12-month price target for the stock has increased by 24.82% from the previous average, now standing at $15.29.
November 07, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sabra Health Care REIT has received mixed analyst ratings, but the average 12-month price target has increased significantly.
The mixed analyst ratings indicate uncertainty about the stock's performance. However, the significant increase in the average 12-month price target suggests that analysts are generally optimistic about the stock's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100